Open access · CC-BY
via OpenAlex
Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study
Ana Clara da C. Pinaffi‐Langley, Camila Bonin Pinto, Zsófia Szarvas, Anna Péterfi, Zalan Kaposzta, Péter Mukli, Mihaly Muranyi, Cameron D. Owens, Cheryl Adams, Ali Shahriari, Henry Kinnard, Bryan Ticer, Leah Anderson, Stefano Tarantini, Yan Daniel Zhao
Clinical Nutrition Open Science · 2025 · ▲ 6 citations
Abstract
Background & Aims Obesity-related mitochondrial dysfunction(definition) initiates and exacerbates endothelial dysfunction, which in turn contributes to the development of several diseases, such as cardiovascular disease and cognitive impairment. Urolithin A (UroA) is a polyphenol-derived microbial metabolite with mitophagy activator activity. Although the safety, pharmacokinetics, and effects of UroA supplementation on muscle health have been investigated in humans, its potential to mitigate endothelial dysfunction in obese adults remains unknown. Thus, this protocol details the procedures of a study designed to investigate the effect of 4 weeks of UroA supplementation on endothelial and cerebrovascular function in middle-aged adults with obesity. Methods This study is a placebo-controlled, double-blind, randomized, parallel interventional trial. Eligible participants are between 40–64 years old and have a BMI ≥30 kg/m 2 . Enrolled participants are randomized to receive active (1,000 mg of UroA daily) or control (placebo) intervention for 4 weeks. Before and after the intervention, they undergo peripheral micro- and macrovascular endothelial function and cerebrovascular function assessments. Results We expect that those who receive UroA supplementation will have a significant improvement in endothelial and cerebrovascular function compared with those who receive placebo. Conclusion The results of this trial will provide important insights into the effect of UroA on endothelial dysfunction in adults with obesity. Trial registration This study was prospectively registered at ClinicalTrials.gov on June 26, 2023 (NCT05921266).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.nutos.2025.04.004
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Pinaffi‐Langley, A.C.D.C., Pinto, C.B., Szarvas, Z., Péterfi, A., Kaposzta, Z., Mukli, P., Muranyi, M., Owens, C.D., Adams, C., Shahriari, A., Kinnard, H., Ticer, B., Anderson, L., Tarantini, S., Zhao, Y.D., Hord, N.G., & Yabluchanskiy, A. (2025). Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study. <em>Clinical Nutrition Open Science</em>. https://doi.org/10.1016/j.nutos.2025.04.004
Vancouver
Pinaffi‐Langley ACDC, Pinto CB, Szarvas Z, Péterfi A, Kaposzta Z, Mukli P, et al. Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study. Clinical Nutrition Open Science. 2025. doi:10.1016/j.nutos.2025.04.004.
BibTeX
@article{ana2025Urolit,
title = {Urolithin A supplementation to improve endothelial and cerebrovascular function in middle-aged adults with obesity: Study protocol for a double-blind placebo-controlled randomized study},
author = {Ana Clara da C. Pinaffi‐Langley and Camila Bonin Pinto and Zsófia Szarvas and Anna Péterfi and Zalan Kaposzta and Péter Mukli and Mihaly Muranyi and Cameron D. Owens and Cheryl Adams and Ali Shahriari and Henry Kinnard and Bryan Ticer and Leah Anderson and Stefano Tarantini and Yan Daniel Zhao and Norman G. Hord and Andriy Yabluchanskiy},
journal = {Clinical Nutrition Open Science},
year = {2025},
doi = {10.1016/j.nutos.2025.04.004},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Amazentis SA 2023
Open access · US-GOV
Impact of Urolithin A Supplementation on Mitochondrial Health of Immune Cells (MitoImmune): a Randomized Trial
University of Vienna 2026
Open access · US-GOV
Collagen Peptides and Cellular Aging: a Randomized, Placebo-controlled Intervention Study on Telomere Length, Inflammation, Body Composition, and Functional Capacity in Middle-aged and Older Adults
University of Miami 2026
Open access · US-GOV
A Feasibility Study Examining the Comparison of Transcendental Meditation Versus Health Education on Psychological and Hemodynamic Function in Post-menopausal Women
PLoS ONE 2024
Open access · CC-BY
Time-restricted eating for prevention of age-related vascular cognitive decline in older adults: A protocol for a single-arm open-label interventional trial
Ohio State University 2025
Open access · US-GOV
Internet-based Mind-Body Training (iMBT) for Brain Health
Amazentis SA 2024
Open access · US-GOV